Ottobock worldwide Revenue and Competitors

Ottobock sets standards: For more than 100 years, Ottobock develops innovative products. Meanwhile, the med-tech company also takes care of the full treatment cycle all over the globe. These services are provided under the Ottobock SE & Co. KGaA name, which began in 2018 to channel the company's med-tech expertise into sustainably healthy workplaces. We continually develop our company and perfect our technology to improve the lives of our users. In 2019, we invested 9% of our turnover of product sales in research and development. Since 1919 products and technologies from Ottobock have been helping people gain new freedom of movement and avoid potential complications. Initially, the company revolutionised the market – above all treatment for patients – thanks to the series production of prosthetic components. Since then, the focus has turned to microprocessor-controlled knee joints such as the C-Leg (which can be controlled via an app), the computer-controlled C-Brace leg orthosis, the multi-articulating bebionic hand, Juvo power wheelchairs and the Paexo exoskeleton range for ergonomic workplaces. Our single-minded determination to improve quality of life has made us a global leader in technology for wearable human bionics, which enhance or replace parts of the human body. Ottobock at a glance: • €1.003 million turnover in 2019 • Over 7,000 employees in more than 50 countries across the world • More than 160 company-operated patient care centres • Global market leader in prosthetics Do you want to work at Ottobock? Visit www.ottobock.com/en/career/jobs Data Privacy, Imprint, Legal Terms - Visit www.ottobock.com/socialmedialinks